Is Big Pharma getting too cozy with doctors?

Donald Caminiti

Contributor

0 CommentsPrint ArticleSubscribe

Well respected members of the medical community are increasingly calling on their colleagues to quell the influence of big pharma in research and prescribing practices. In recent months, top medical schools and teaching hospitals have limited interaction between drug sales representatives and doctors while a top medical journal has come out in favor of litigation as a valuable tool to combat drugmaker misconduct. It is perhaps time to rethink whether the tv ads for prescription drugs are really in the public interest.